Weinheimer M - Search Results

1

Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape.

Price E, Weinheimer M, Rivkin A, Jenkins G, Nijsen M, Cox PB, DeGoey D. Price E, et al. Among authors: weinheimer m. J Med Chem. 2024 Apr 11;67(7):5683-5698. doi: 10.1021/acs.jmedchem.3c02332. Epub 2024 Mar 18. J Med Chem. 2024. PMID: 38498697

2

Interlaboratory Variability in the Madin-Darby Canine Kidney Cell Proteome.

Harwood MD, Zettl K, Weinheimer M, Pilla-Reddy V, Shen H, Jacobs F, Chu X, Huth F, Nakakariya M, Chothe PP, Neuhoff S, Wiśniewski JR. Harwood MD, et al. Among authors: weinheimer m. Mol Pharm. 2023 Jul 3;20(7):3505-3518. doi: 10.1021/acs.molpharmaceut.3c00108. Epub 2023 Jun 7. Mol Pharm. 2023. PMID: 37283406 Free PMC article.

3

Correction: Improvement of Workfows and Assay Reproducibility by The Introduction of "Assay-Ready" Culturing of MDCK Cells for Transport Studie.

Muschong P, Jin L, Schejbal J, Mezler M, Weinheimer M. Muschong P, et al. Among authors: weinheimer m. Pharm Res. 2023 Jun;40(6):1599. doi: 10.1007/s11095-023-03510-3. Pharm Res. 2023. PMID: 37072641 No abstract available.

4

Improvement of Workflows and Assay Reproducibility by The Introduction of "Assay-Ready" Culturing of MDCK Cells for Transport Studies.

Muschong P, Jin L, Schejbal J, Mezler M, Weinheimer M. Muschong P, et al. Among authors: weinheimer m. Pharm Res. 2023 May;40(5):1259-1270. doi: 10.1007/s11095-023-03490-4. Epub 2023 Mar 28. Pharm Res. 2023. PMID: 36977814

5

Mucin-Protected Caco-2 Assay to Study Drug Permeation in the Presence of Complex Biorelevant Media.

Ye D, López Mármol Á, Lenz V, Muschong P, Wilhelm-Alkubaisi A, Weinheimer M, Koziolek M, Sauer KA, Laplanche L, Mezler M. Ye D, et al. Among authors: weinheimer m. Pharmaceutics. 2022 Mar 24;14(4):699. doi: 10.3390/pharmaceutics14040699. Pharmaceutics. 2022. PMID: 35456533 Free PMC article.

6

Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.

Ye D, Harder A, Fang Z, Weinheimer M, Laplanche L, Mezler M. Ye D, et al. Among authors: weinheimer m. Pharm Res. 2020 Sep 11;37(10):194. doi: 10.1007/s11095-020-02895-9. Pharm Res. 2020. PMID: 32918191

7

In Silico Examination of Initiation of Long-Acting Insulin Analogs Toujeo Compared to Lantus Under 3 Dosing Titration Rules in Virtual Type 2 Diabetes Subjects.

Sieber J, Weinheimer M, Kongable G, Riddle S, Chang YY, Flacke F. Sieber J, et al. Among authors: weinheimer m. J Diabetes Sci Technol. 2020 Sep;14(5):898-907. doi: 10.1177/1932296819861586. Epub 2019 Jul 9. J Diabetes Sci Technol. 2020. PMID: 31288531 Free PMC article.

8

The application of P-gp inhibiting phospholipids as novel oral bioavailability enhancers - An in vitro and in vivo comparison.

Weinheimer M, Fricker G, Burhenne J, Mylius P, Schubert R. Weinheimer M, et al. Eur J Pharm Sci. 2017 Oct 15;108:13-22. doi: 10.1016/j.ejps.2016.08.055. Epub 2016 Aug 30. Eur J Pharm Sci. 2017. PMID: 27590127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page